Atai Beckley N.V Common Shares (ATAI)
Atai Beckley N.V Common Shares
XNAS:ATAI
3.86
$6.25 - 3.00
$3.78 - 500.00
$3.78
$3.95
$3.8
$3.75
6.75
1.15
2276852
4292579.5
272517098.13
Chart
TendieTensor AI Analysis
Company
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
Fundamentals
54
-4.840000
5.854730
-0.28
100
214.34M
363.11M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ATAI. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.